The links below provide details for each of the major funding bodies and current funding opportunities. Detailed information on funding rules, contacts, key dates, application deadlines and resources can be found on their websites.
The CRN may provide limited support to conferences that meet CRN criteria. The provision of conference support will be negotiated with the applicant(s) on a case-by-case basis. Support may include, but is not limited to, the provision of:
For full details, please refer to:
Guidelines for Conference Support (Pdf, 73.6kb)
Application form (Word, 109.1kb)
For further information, please contact the Cancer Research Network Office on 8627 1532 or by email.
The Pathology Support Laboratory (PSL) has been established within the Children’s Hospital at Westmead Tumour Bank to facilitate research through the provision of research-based tissue handling techniques which may be of interest to University of Sydney cancer researchers using biospecimens as part of their research. PSL services include:
For further details, please contact:
The Tumour Bank, The Oncology Research Unit, The Children’s Hospital at Westmead, Locked Bag 4001, Westmead NSW 2145
Phone: 02 98451205 or 02 98453028
Sydney Bioinformatics offers a suite of professional bioinformatics services including: collaborative research, expert assistance, advice, consultancy as well as customised data analysis and software development.
Vocational and educational training in the use of bioinformatics is a key service provided to postgraduate students, research staff and academic staff. Sydney Bioinformatics is home to the Australian National Genomic Information Service (ANGIS) and can provide access to online bioinformatics software for cancer research.
For further details, please visit:
The Commercial Development and Industry Partnerships (CDIP) is the commercial arm of the University of Sydney. The main mission of CDIP is to ensure that technologies and innovations from the University of Sydney will develop into successful products. As a publicly funded institution, the University sees this as one of the ways in which it can serve the people that support its activities. CDIP is responsible for the identification, protection and licensing of intellectual property developed at the University.
CDIP holds a large portfolio of novel and exciting technologies that cover the entire spectrum of modern science, including cancer. CDIP invites industrial partners and entrepreneurs to team up with them in turning these technologies into useful and successful products.
For further details, visit industry partners.